Allegiant Health
Generated 5/10/2026
Executive Summary
Allegiant Health is a global manufacturer of over-the-counter (OTC) pharmaceuticals and nutritional supplements, founded in 2017 and headquartered in Nashville, USA. The company operates a robust manufacturing and packaging platform, offering over 200 products under its proprietary HealthA2Z brand as well as private-label and contract manufacturing services. With a strong focus on innovation and quality control, Allegiant has established a significant international presence, particularly in the Chinese-Asian market, where it leverages its capabilities to meet diverse consumer needs. The company's integrated supply chain and scalable production capacity position it as a competitive player in the growing OTC and supplement sectors, serving both branded and white-label customers across multiple geographies.
Upcoming Catalysts (preview)
- Q3 2026Expansion of HealthA2Z product line into new therapeutic categories (e.g., probiotics, sleep aids)60% success
- Q2 2026Strategic distribution partnership with a major Asian retailer or e-commerce platform70% success
- Q4 2026FDA approval for a new OTC monogram drug under the HealthA2Z brand50% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)